Folgen
Dr. Raghavendra Kumar Gunda
Dr. Raghavendra Kumar Gunda
Associate Professor, Narasaraopeta Institute of Pharmaceutical Sciences
Bestätigte E-Mail-Adresse bei vignan.ac.in
Titel
Zitiert von
Zitiert von
Jahr
Formulation development and evaluation of rosiglitazone maleate sustained release tablets using 32 factorial design
RK Gunda
Int J Pharm Tech Res 8 (4), 713-724, 2015
542015
Formulation development and evaluation of lamotrigine sustained release tablets using 32 factorial design
RK Gunda, JNS Kumar, CA Babu, MV Anjaneyulu
International Journal of Pharmaceutical Sciences and Research 6 (4), 1746, 2015
382015
Design, formulation and evaluation of atenolol gastro retentive floating tablets
RK Gunda
Asian Journal of Pharmaceutics (AJP) 9 (4), 2015
282015
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Systems- A Review
RK Gunda
Journal of Pharmacy Research 11 (2), 167-178, 2017
252017
Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
JNSK Raghavendra Kumar Gunda
FABAD Journal of Pharmaceutical Sciences 43 (2), 15-25, 2018
192018
Design, formulation and evaluation of pravastatin fast dissolving tablets
JNS Kumar, RK Gunda
Pharm Met 9, 16-23, 2018
172018
Statistical design and optimization of sustained release formulations of Pravastatin
PRM RK Gunda
Turkish Journal of Pharmaceutical Sciences 17 (2), 221-7, 2020
152020
Formulation development and evaluation of gastro retentive bio adhesive drug delivery system for moxifloxacin. HCL
RK Gunda, A Vijayalakshmi
Ind J Pharm Edu Res 53 (4), 724-32, 2019
152019
Design, development, and in vitro evaluation of sustained release tablet formulations of olmesartan medoxomil
RK Gunda, PR Manchineni, D Dhachinamoorthi
MOJ Drug Des Develop Ther 7 (3), 164-169, 2018
132018
Formulation Development and Evaluation of Moxifloxacin. Hcl Fast Dissolving Tablets.
NSK Gunda, Raghavendra Kumar, Jujjuru
Pharm Methods 8 (2), 160-167, 2017
13*2017
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
CMH Raghavendra Kumar Gunda*1, J. N. Suresh Kumar1, V. Satyanarayana2 ...
Journal of Pharmacy Research , 10 (5), 216-225, 2016
122016
Formulation Development and Evaluation of Carvedilol Phopsphate Gastro Retentive Floating Tablets
VS RK Gunda, JNS Kumar
International Research Journal of Pharmacy 7 (1), 44-51, 2016
122016
Formulation Development and Evaluation of Gastro Retentive Floating Drug Delivery System for Novel Fluoroquinolone using Natural and Semisynthetic Polymers: Formulation …
RK Gunda, A Vijayalakshmi
Iranian Journal of Pharmaceutical Sciences 16 (1), 49-60, 2020
112020
Statistical design, formulation and evaluation of gastro retentive floating tablets for moxifloxacin using natural and semisynthetic polymers
AV RK Gunda
Thai Journal of Pharmaceutical Sciences (TJPS) 43 (3), 138-45, 2019
11*2019
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets: Clopidogrel fast dissolving tablets
GR Kumar, JNS Kumar, V Satyanarayana, GS Rani, BS Prasad
Iranian Journal of Pharmaceutical Sciences 12 (2), 61-74, 2016
112016
Development and evaluation of gastroretentive formulations for moxifloxacin hydrochloride
RK Gunda, A Vijayalakshmi, K Masilamani
The Thai Journal of Pharmaceutical Sciences 44 (1), 30-39, 2020
102020
Formulation development and in vitro evaluation of oral disintegrating tablets for newer anticonvulsant agent
RK Gunda, PR Manchineni, CG Reddy
J Anal Pharm Res 8 (2), 85-89, 2019
102019
Formulation development and evaluation of Zidovudine sustained release tablets using 32 factorial design
RK Gunda, JNS Kumar
Der Pharmacia Sinica 6 (6), 59-67, 2015
102015
Design, development, optimization and evaluation of ranolazine extended release tablets
RK Gunda, PR Manchineni, D Duraiswamy, KR Gsn
Turkish Journal of Pharmaceutical Sciences 19 (2), 125, 2022
92022
A statistical study on the formulation development of sustained release tablets for valsartan sodium
VT RK Gunda, PR Manchineni
MOJ Drug Des Develop Ther 2 (5), 217-222, 2018
92018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20